Paediatric Respiratory Reviews儿科呼吸评论
Paediatric Respiratory Reviews(英文缩写 PAEDIATR RESPIR REV),ISSN 1526-0542,eISSN 1526-0550,中文译名:儿科呼吸评论 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-10-01 至 2026-09-30，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 5.526 | Q1 |
| 2022 | 5.800 | Q1 |
| 2023 | 4.700 | Q1 |
| 2024 | 4.000 | Q1 |
| 2025 | 3.400 | Q1 |
Paediatric Respiratory Reviews 最新收录文献
-
1. Growth and nutrition in early life for very preterm infants - Implications for neonatal lung health.
PMID:日期:2026-09-08Very preterm birth (< 32 weeks' gestation) disrupts a critical window of lung development, placing infants at substantial risk of bronchopulmonary dysplasia (BPD) and long-term respiratory morbidity. Nutrition is increasingly recognised as a modifiable determinant of neonatal lung health across three distinct but interconnected phases: (1) During the antenatal period, maternal macronutrient and micronutrient status, including vitamin D, omega-3 fatty acids, and folate, shapes placental function, fetal lung growth, and surfactant biosynthesis. Fetal growth restriction, a consequence of placental insufficiency, profoundly impairs pulmonary vascular and alveolar development. (2) In the neonatal intensive care unit, early aggressive parenteral nutrition followed by optimised enteral feeding with human milk reduces BPD risk, while targeted macronutrient delivery and specific micronutrient supplementation support ongoing alveolarisation. (3) After hospital discharge, catch-up growth and sustained human milk feeding are associated with improved lung function, reduced respiratory hospitalisation, and lower rates of recurrent wheeze. This review synthesises current evidence and translates it into practical guidance across all three phases, to optimise nutritional strategies for vulnerable infants.
-
2. {"_":"Change is coming? The concept of FEV change score in predicting asthma exacerbations.","sub":["1"]}
PMID:日期:2026-07-18Guidlines recommend that current asthma symptom control should inform asthma preventer treatment to reduce future asthma exacerbations. But current symptom control is not a reliable predictor of exacerbation. There is a need for an objective measure of lung function to support asthma preventer treatment decision-making in order to reduce risk for future asthma exacerbations in children with asthma. Historically FEV was recommended as part of routine monitoring for childhood asthma, but not all current guidelines recommend regular FEV measurements are made and this is, in part, due to a lack of evidence linking change in FEV and future asthma outcomes. Recent work supports the use of conditional change score (Zc) as a method to express change in FEV over time; Zc adjusts for age and interval between measurements and, unlike absolute change in FEV% or FEV z score, Zc is not liable to regression to the mean. Changes in Zc are associated with future exacerbation risk and also future loss of asthma control. Rising and falling Zc are both associated with increased odds for future exacerbation whereas only falling Zc is associated with increased odds for future loss of asthma control. Randomised controlled trials are now required to determine the role of Zc in the management of childhood asthma.
-
3. Travelling with a child on ventilatory support: How to plan and avoid potential pitfalls.
3. 带着接受通气支持的孩子旅行：如何计划和避免潜在的陷阱PMID:日期:2026-07-17Travel for families of children with complex medical needs can offer significant benefits for family wellbeing and quality of life, yet it is often perceived as complex and high risk. As the population of technology-dependent children increases, the need to support safe and feasible travel has become more prominent. Families face multiple barriers, including the need to maintain continuity of care, transport essential equipment and medications, navigate variable regulations, and coordinate extensive documentation across healthcare and travel systems. These demands, alongside financial costs and administrative burden, frequently contribute to increased anxiety and risk aversion. Experiential accounts from parents demonstrate that travel for this cohort of children is safe, achievable, and rewarding with comprehensive and anticipatory planning across key domains, including destination selection, accommodation suitability, equipment and oxygen provision, medication and nutrition management, transport arrangements, and emergency preparedness. Healthcare professionals play a crucial role in supporting families through pre-travel assessment, documentation, and risk mitigation strategies. With appropriate preparation and multidisciplinary collaboration, travel can be undertaken safely, enabling families to access important psychosocial benefits while minimising potential clinical risks.
-
4. Long-term respiratory outcomes of infants born moderate to late preterm.
PMID:日期:2026-06-30Moderate to late preterm birth, defined as birth between 32 to <37 weeks' gestation, accounts for over 80% of all preterm births globally. Although long-term respiratory outcomes following very and extremely preterm birth are well characterised, the lifelong respiratory consequences of moderate to late preterm birth have received comparatively less attention. Infants born moderate to late preterm experience increased neonatal respiratory morbidity, greater susceptibility to early-life lower respiratory tract infection, and elevated rates of wheeze and physician-diagnosed asthma throughout childhood compared with peers born at term. Individuals born moderate to late preterm demonstrate modest decrements in expiratory airflow relative to those born at term, with emerging evidence of sex-specific trajectories, impaired gas transfer, and an increased risk of chronic obstructive pulmonary disease (COPD) in mid-adulthood. In this review, we position moderate to late preterm birth within the framework of prematurity-associated lung disease (PLD), present contemporary estimates of expiratory airflow via meta-analysis, and outline priorities for mechanistic, interventional and translational research in this large gestational group.
-
5. Image-guided pediatric airway endoscopy: A review.
PMID:日期:2026-06-12Pediatric airway endoscopy, including nasopharyngolaryngoscopy (NPL), microlaryngobronchoscopy (MLB), and flexible bronchoscopy, plays an essential role diagnosing and managing airway disorders in children. Each technique offers unique distinct advantages, and when paired with imaging modalities such as X-rays, fluoroscopy, computed tomography (CT), and magnetic resonance imaging (MRI), clinicians gain a more comprehensive and accurate assessment of the airway. This review explores the complementary role of endoscopy and imaging in pediatric airway evaluation, emphasizing how their combined use improves diagnostic accuracy, guides treatment planning, and facilitates multidisciplinary care. While endoscopy remains the gold standard for visualizing airway pathology, integrating imaging enhances understanding of both structural and functional abnormalities, ultimately improving clinical outcomes in this vulnerable patient population.
-
6. Bronchoscopic and interventional management of tracheobronchomalacia in children with bronchopulmonary dysplasia: a review of evidence.
PMID:日期:2026-06-10Tracheobronchomalacia (TBM) remains a challenging condition in pediatric respiratory medicine. It arises from diverse etiologies involving intrinsic tracheal collapse and extrinsic airway compression. Although diagnostic criteria have progressed over time, flexible bronchoscopy remains the gold standard, as it enables direct assessment of dynamic airway changes, with a >50% reduction in airway lumen during forced expiration considered indicative of TBM. TBM represents one of the principal consequences of bronchopulmonary dysplasia (BPD) and plays a decisive role in the clinical course of affected children. The pathophysiological connection between BPD and TBM stems from multiple factors: prolonged mechanical ventilation, chronic inflammation, and altered development of airway cartilage in premature infants. Pharmacological treatment plays a key role in managing large airway disease (LAD) in infants with severe BPD by optimizing airway stability and reducing respiratory distress. Chest physiotherapy can enhance mucociliary clearance and support respiratory mechanics in patients with TBM, while in more severe cases surgical or bronchoscopic interventions, such as airway stenting, are often required. TBM in the context of BPD adds substantial clinical complexity, necessitating a comprehensive understanding of disease mechanisms and individualized therapeutic strategies. Evidence supporting available interventions is heterogeneous; non-invasive ventilation strategies hold the strongest support from randomized controlled trials, whereas bronchoscopic and surgical procedures rely largely on observational studies, case series, and expert opinion. This variability underscores the need for further research, particularly controlled trials comparing different management strategies where ethically and practically feasible.
-
7. Moving the goalposts from symptom control to preventing airway remodeling in preschool asthma.
PMID:日期:2026-06-09Recurrent wheezing in preschool aged children is a common reason for consultation to the pediatric respirologist. However, the definition of preschool asthma, the various phenotypes and associated investigations required to define these phenotypes, the goals of therapy, and considerations for therapeutics, including biologics, are all areas needing further development. Let's begin with an illustrative case.
-
9. How to monitor response to biologics in children with severe asthma.
PMID:日期:2026-06-06Severe paediatric asthma imposes a substantial health and financial burden. Biologics-monoclonal antibodies targeting specific asthma inflammatory pathways, are transforming severe asthma management. Currently approved biologics for paediatric use (≥6 or ≥12 years of age) include anti-immunoglobulin E (omalizumab), anti-interleukin (IL)-5 (mepolizumab), ultra-long acting anti-IL5 (depemokimab), anti-IL-5 receptor (benralizumab), anti-IL4/IL-13 (dupilumab), and anti-thymic stromal lymphopoietin (TSLP) (tezepelumab). While clinical trials have shown promising results, real-world data on long-term efficacy and safety in children and adolescents remain limited. Moreover, guidelines for initiating, monitoring biologics and assessing treatment response varies across countries lacking consensus. This is the second in a series of narrative reviews on biologics in severe paediatric asthma. The first review summarised key clinical trials findings and offered practical guidance for initiating therapy. In this review, we focus on strategies for monitoring treatment response, the role of asthma biomarkers and the potential of emerging therapies. We also highlight current research gaps and future directions to optimise biologics use in children and adolescents with severe asthma.
-
10. Phenotyping bronchopulmonary dysplasia using magnetic resonance imaging.
10. 使用磁共振成像对支气管肺发育不良进行表型分析PMID:日期:2026-06-06Bronchopulmonary dysplasia (BPD) is characterized by impaired lung development and persistent respiratory morbidity. BPD comprises three primary phenotypes: parenchymal, airway, and pulmonary vascular disease. Parenchymal disease involves disrupted alveolar growth, emphysema, hyperinflation, inflammation, and fibrosis, leading to impaired gas exchange. Airway disease, including airway malacia and subglottic stenosis, causes airflow obstruction and increased work of breathing. Pulmonary vascular disease involves abnormal vascular remodeling and increased pulmonary vascular resistance, which contributes to the development of pulmonary hypertension. Imaging plays a central role in evaluating these phenotypes which may occur independently or overlap with other phenotypes. Advanced MRI techniques enable non-invasive assessment of lung structure, ventilation, perfusion, airway shape and dynamics, vascular remodeling, and ventricular morphology and function. Imaging-based phenotyping can enhance disease monitoring, risk stratification, and help to inform personalized management strategies in infants with BPD.